Pharma Industry News

NICE nod for Almirall’s Ilumetri, UCB’s Cimzia

NICE has recommended Almirall's Ilumetri and UCB's Cimzia as treatment options for severe plaque psoriasis in final draft guidelines.Original Article

About the author

David Miller

a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.

[mwai_chat window="true" fullscreen="true"]